Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Since the discovery of the anticancer potential of ruthenium-based complexes, several species were reported as promising candidates for the treatment of breast cancer, which accounts for the greatest number of new cases in women every year worldwide. Among these ruthenium complexes, species containi...
Main Authors: | Golara Golbaghi, Annie Castonguay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/2/265 |
Similar Items
-
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01) -
Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
by: Lisa D. Yee, et al.
Published: (2020-02-01) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01) -
PD-L1 expression in triple-negative breast cancer: a cross-sectional study in a Polish population
by: Łukasz Szylberg, et al.
Published: (2021-02-01)